| Product Code: ETC7548796 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India neurodegenerative disease treatment market import shipments exhibited robust growth with a significant CAGR from 2020 to 2024. The growth rate between 2023 and 2024 accelerated further, indicating a strong upward momentum in market expansion during this period.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Neurodegenerative Disease Treatment Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Neurodegenerative Disease Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 India Neurodegenerative Disease Treatment Market - Industry Life Cycle |
3.4 India Neurodegenerative Disease Treatment Market - Porter's Five Forces |
3.5 India Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 India Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Drug Type:, 2021 & 2031F |
3.7 India Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Route of Administration:, 2021 & 2031F |
3.8 India Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Distribution Channel:, 2021 & 2031F |
4 India Neurodegenerative Disease Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurodegenerative diseases in India |
4.2.2 Growing awareness and focus on healthcare infrastructure and services |
4.2.3 Technological advancements in treatment options for neurodegenerative diseases |
4.3 Market Restraints |
4.3.1 High treatment costs and limited access to healthcare services for a significant portion of the population |
4.3.2 Regulatory challenges and approval processes for new treatment options |
4.3.3 Lack of skilled healthcare professionals specialized in neurodegenerative disease treatment |
5 India Neurodegenerative Disease Treatment Market Trends |
6 India Neurodegenerative Disease Treatment Market, By Types |
6.1 India Neurodegenerative Disease Treatment Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 India Neurodegenerative Disease Treatment Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 India Neurodegenerative Disease Treatment Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F |
6.1.4 India Neurodegenerative Disease Treatment Market Revenues & Volume, By Parkinsons Disease, 2021- 2031F |
6.1.5 India Neurodegenerative Disease Treatment Market Revenues & Volume, By Alzheimers Disease, 2021- 2031F |
6.1.6 India Neurodegenerative Disease Treatment Market Revenues & Volume, By Spinal Muscular Atrophy (SMA), 2021- 2031F |
6.1.7 India Neurodegenerative Disease Treatment Market Revenues & Volume, By Huntingtons Disease, 2021- 2031F |
6.1.8 India Neurodegenerative Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 India Neurodegenerative Disease Treatment Market, By Drug Type: |
6.2.1 Overview and Analysis |
6.2.2 India Neurodegenerative Disease Treatment Market Revenues & Volume, By N-methyl-D-aspartate Receptor Antagonists, 2021- 2031F |
6.2.3 India Neurodegenerative Disease Treatment Market Revenues & Volume, By Selective Serotonin Reuptake Inhibitors, 2021- 2031F |
6.2.4 India Neurodegenerative Disease Treatment Market Revenues & Volume, By Dopamine Inhibitors, 2021- 2031F |
6.2.5 India Neurodegenerative Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.3 India Neurodegenerative Disease Treatment Market, By Route of Administration: |
6.3.1 Overview and Analysis |
6.3.2 India Neurodegenerative Disease Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 India Neurodegenerative Disease Treatment Market Revenues & Volume, By Injectable, 2021- 2031F |
6.3.4 India Neurodegenerative Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 India Neurodegenerative Disease Treatment Market, By Distribution Channel: |
6.4.1 Overview and Analysis |
6.4.2 India Neurodegenerative Disease Treatment Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 India Neurodegenerative Disease Treatment Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.4 India Neurodegenerative Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 India Neurodegenerative Disease Treatment Market Import-Export Trade Statistics |
7.1 India Neurodegenerative Disease Treatment Market Export to Major Countries |
7.2 India Neurodegenerative Disease Treatment Market Imports from Major Countries |
8 India Neurodegenerative Disease Treatment Market Key Performance Indicators |
8.1 Number of clinical trials and research studies conducted on neurodegenerative diseases in India |
8.2 Adoption rate of new treatment technologies and therapies in the market |
8.3 Patient satisfaction and outcomes measures for neurodegenerative disease treatments |
9 India Neurodegenerative Disease Treatment Market - Opportunity Assessment |
9.1 India Neurodegenerative Disease Treatment Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 India Neurodegenerative Disease Treatment Market Opportunity Assessment, By Drug Type:, 2021 & 2031F |
9.3 India Neurodegenerative Disease Treatment Market Opportunity Assessment, By Route of Administration:, 2021 & 2031F |
9.4 India Neurodegenerative Disease Treatment Market Opportunity Assessment, By Distribution Channel:, 2021 & 2031F |
10 India Neurodegenerative Disease Treatment Market - Competitive Landscape |
10.1 India Neurodegenerative Disease Treatment Market Revenue Share, By Companies, 2024 |
10.2 India Neurodegenerative Disease Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here